← Back
$MLYS All transactions

Mineralys Therapeutics, Inc.

▼ SELL 10b5-1 Plan

$ Value

$75K

Shares

2,065

Price

$36

Filed

Sep 16

Insider

Name

Rodman David Malcom

Title

Chief Medical Officer

CIK

0001672659

Roles

Officer

Transaction Details

Transaction Date

2025-09-15

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

81,524

Footnotes

These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 25, 2024. | The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $35.4000 to $36.3955. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. | The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $36.4026 to $36.7005. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.

Filing Info

Accession No.

0001672659-25-000006

Form Type

4

Issuer CIK

0001933414

Rodman David Malcom's History

Date Ticker Type Value
2026-04-17 MLYS M $6K
2026-04-17 MLYS $13K
2026-04-17 MLYS M $0
2026-04-15 MLYS $176K
2026-04-13 MLYS M $7K
2026-04-13 MLYS M $36K
2026-04-13 MLYS M $59K
2026-04-13 MLYS $373K
2026-04-13 MLYS M $0
2026-04-13 MLYS M $0

Other Insiders at MLYS (90d)

Insider Bought Sold Last
RA CAPITAL MANAGEMENT, L.P. $8.8M 2026-03-30
Congleton Jon
Chief Executive Officer
$2.4M 2026-04-13
Rodman David Malcom
Chief Medical Officer
$621K 2026-04-17
Karydas Daphne $75K 2026-03-31